Back to results
US 11,014,884 B2Granted
Modulators of hemoglobin
AssigneeGlobal Blood Therapeutics, Inc.
InventorsBrian W. Metcalf, Zhe Li, Qing Xu, Kobina N. Dufu, James Partridge, Hing Sham, Ming Yu
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Claims60
A compound of formula (I):
- or an isotopically enriched analog, stereoisomer, or mixture of stereoisomers thereof, or a pharmaceutically acceptable salt of each thereof,
- wherein:
- ring A is aryl or heteroaryl, wherein ring A is optionally substituted with 1-3 R3;
- ring B is aryl, nitrogen-containing heteroaryl, or nitrogen-containing heterocyclyl, wherein ring B is optionally substituted with 1-3 R4;
- L is absent, —C(O)—, —C(O)O—, or —CH2—;
- R1 is —C(O)H;
- R2 is H or OH;
- each R3 is independently halo, hydroxy, C1-3 alkyl, C2-3 alkenyl, C1-3 alkoxy, C1-3 haloalkyl, or C1-3 haloalkoxy;
- and
- each R4 is independently oxo, C1-3 alkyl, C1-3 alkoxy, C1-3 haloalkyl, C1-3 haloalkoxy, or C3-5 cycloalkyl.
7 more elements
A compound of formula:
- or a pharmaceutically acceptable salt thereof.
A compound of formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.